Research, News & Discoveries

Vanderbilt trainees and postdocs explored Nashville’s biotech scene, starting with contract research organization Inotiv. Read More

In a new study published in Diabetes, researchers found that prolonged treatment with the GLP-1R agonist semaglutide led to changes in feeding habits and fuel use in an animal model, offering new insights into the behavioral and metabolic adaptations that accompany weight loss, weight maintenance, and rapid weight regain after stopping treatment. Read More

Meet Prashant Singh, senior research associate in the Tina Iverson lab within the School of Medicine Basic Sciences. Read More

The lab of Kris Burkewitz just made a key discovery: How cellular machineries are structured and organized within a cell has implications for healthy aging. “We didn't just add a piece to the puzzle—we found a whole section that hasn't even been touched,” Eric Donahue, first author of the study, said. Read More

Meet Jen Silverman, a Ph.D. candidate in the lab of Matthew Tyska in the Department of Cell and Developmental Biology. Read More

Millions of Americans struggle with cocaine use, yet research tools don’t yet reflect real-world drug use. Vanderbilt scientists have developed a new approach that more accurately models how people use cocaine, strengthening efforts to understand addiction and develop better therapies Read More

Kavya Sharman, BS’16, PhD’22, channeled dual expertise in science and business into launching Phase Capital, a Nashville-based venture capital firm focused on tech bio. Today, she supports founders working to transform scientific discoveries into scalable applications across the U.S., all while maintaining close ties to her Vanderbilt alma mater and home. Read More

Emeson was one of the first scientists to explore a newly discovered biological process called RNA editing, a mechanism by which cells can subtly change the function of proteins and non-coding RNAs to fine-tune their activities. His team’s pioneering research made seminal contributions to the field and laid the foundation for understanding how RNA editing contributes to the regulation of neuronal function. Reflecting on his career, Emeson said the best things have been “the science, the students, the opportunity to work with talented colleagues, and the IACUC.” Read More

National Cancer Institute molecular biologist André Nussenzweig delivered a School of Medicine Basic Sciences Apex Lecture on Dec. 15 about genome stability in mitotic and post-mitotic cells. Read More